Qualitative factors shaping MS patients’ experiences of infusible disease-modifying drugs: a critical incident technique analysis
J.L. Larsen, Peter Vestergaard Rasmussen(Aarhus University Hospital), Helle Hvilsted Nielsen(Odense University Hospital), Jakob Schäfer(Aalborg University Hospital)
Cited by 4
Related Papers
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
|Journal of Neurology Neurosurgery & Psychiatry|2016|297
Remote Ischemic Perconditioning as an Adjunct Therapy to Thrombolysis in Patients With Acute Ischemic Stroke
|Stroke|2013|282
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
Initial high-efficacy disease-modifying therapy in multiple sclerosis
|Neurology|2020|160